María J Pajares

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 4

Top Topics

Polycystic Ovary Syndrome

Body Mass Index

Signaling Pathway

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J Pajares, Saioa Goñi, José-Ignacio Riezu-Boj, Fermin Ignacio Milagro, Josune Ayo, Ignacio J Encío, Miguel Barajas, Miriam Araña
Pediococcus acidilactici pA1c ® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics 15 (4) (2023)
Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J Pajares, Saioa Goñi, José-Ignacio Riezu-Boj, Fermin Ignacio Milagro, Josune Ayo, Ignacio J Encío, Miguel Barajas, Miriam Araña
Pediococcus acidilactici pA1c ® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics 15 (4) (2023)
Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J Pajares, Saioa Goñi, José-Ignacio Riezu-Boj, Fermin Ignacio Milagro, Josune Ayo, Ignacio J Encío, Miguel Barajas, Miriam Araña
Pediococcus acidilactici pA1c ® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics 15 (4) (2023)
Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J Pajares, Saioa Goñi, José-Ignacio Riezu-Boj, Fermin Ignacio Milagro, Josune Ayo, Ignacio J Encío, Miguel Barajas, Miriam Araña
Pediococcus acidilactici pA1c ® Improves the Beneficial Effects of Metformin Treatment in Type 2 Diabetes by Controlling Glycaemia and Modulating Intestinal Microbiota. Pharmaceutics 15 (4) (2023)